Cannabis Law Report
OCTOBER 26, 2021
to develop and manufacture soft gel capsules of Incannex’s cannabis medicine IHL-42X. The agreement between the two companies will see Procaps making IHL-42X for Incannex’s Phase 2, Phase 3, and open-label clinical trials. According to an article from the Lancet, sleep apnea affects 936 million adults globally.
Cannabis Law Report
AUGUST 7, 2021
Reynolds writes… This Arrogant Man Must Face Tough Questions About his Stance on Cannabis, his Financial Interests and his Breathtaking Hypocrisy. I have a particular interest in epidemiology and clinical trials and in particular running clinical trials in childhood epilepsy.”. Read full article: [link].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SpeedWeed
FEBRUARY 18, 2021
A new study shows that the inhalation of cannabis could be linked to improvements and better quality of life for those with ulcerative colitis. The study was carried out by researchers in Israel, who looked at how inhaling herbal cannabis impacted ulcerative colitis patients over a period of eight weeks, with continued, steady, use.
Cannabis Law Report
MAY 10, 2023
However, a company may be in possession of the most healing psychedelic compound in the world, but unless they can prove it through the clinical trial process, their superior medicine will mean little. Yes, of course, it matters greatly who has the most effective medical psychedelic molecule in specific circumstances.
Cannabis Law Report
JANUARY 2, 2023
Here’s Psychedelics Spotlight’s round-up of 2022 The Intro Today, with progress being made on legislative fronts, multiple clinical trials inching closer to FDA approval, and people simply letting go of the misconceptions and fear they’ve felt towards psychedelics, we find ourselves in a situation where the impossible doesn’t feel so impossible (..)
Cannabis Law Report
JUNE 19, 2022
The market for psychedelic substances is projected to grow rapidly, potentially outpacing the legal US cannabis market. For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art.
Veriheal
JULY 18, 2023
This article will delve into this historic legislation’s potential benefits and implications. Clinical Trials and Reporting The bill breaks new ground by allowing clinical trials to take place regardless of whether the tested substances fall under federal or military statutes. With this step, the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content